Organization | Cycle Pharmaceuticals Ltd.

Cycle Pharmaceuticals Ltd. Report issue

For profit Phase 1

Founded: Cambridge United Kingdom (2012)

Status: No NME R&D (2012)

Organization Overview

First Clinical Trial

2015

NCT02750709

First Marketed Drug

2012

chlorpromazine (Thorazine)

First NDA Approval

None

Last Known Activity

2019

Timeline

NOW

Now

Alternative names

Cycle Pharmaceuticals Ltd. | CYCLE PHARMS LTD

Active Ingredients

Marketed Drugs (6)

chlorpromazine (Thorazine) (1983)

cimetidine (tagamet) (1994)

haloperidol (haldol) (1987)

ketorolac (acuvail) (1997)

nitisinone (orfadin) (2017)

quinidine (1984)

Drugs in Phase 1 Trials (3)

chlorpromazine (Thorazine) (1 trial)

haloperidol (haldol) (2 trials)

nitisinone (orfadin) (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Malnutrition (Phase 1)

Mental Disorders (Phase 1)

Porphyria, Acute Intermittent (Phase 1)

Porphyrias (Phase 1)

Psychomotor Agitation (Phase 1)

Psychotic Disorders (Phase 1)

Tyrosinemias (Phase 1)

Vomiting (Phase 1)

Overview

Highest Phase: Phase 1
# of Trials: 6
# of Trial APIs: 3